Vittorio Maio, PharmD, MS, MSPH

Director, HEOR Fellowship
Program Director, Applied Health Economics and Outcomes Research

Vittorio Maio


901 Walnut Street
10th Floor
Philadelphia, PA 19107

Email Vittorio Maio

215-923-7583 fax

Vittorio Maio, PharmD, MS, MSPH

Director, HEOR Fellowship
Program Director, Applied Health Economics and Outcomes Research

Research & Practice Interests

Appropriateness of Prescribing for the Elderly
Assessment of Quality of Care Provided by Physicians
Evaluation of the Impact of Patient-Centered Medical Home on Utilization and Outcomes of Medical Care
Development of Risk of Hospitalization Models Using Administrative Healthcare Utilization Data


PharmD, University of Perugia (Italy)
MS, Thomas Jefferson University
MSPH, Thomas Jefferson University


Board Certification

Italian Pharmacist

University Appointments

Professor, Jefferson College of Population Health
Program Director, Applied Health Economics & Outcomes Research
Director, Health Economics & Outcomes Research Fellowship


Pharmacoepidemiology (Jefferson College of Life Sciences)


Vittorio Maio is Professor, Program Director of the Applied Health Economics & Outcomes Research; and Director of the Health Economics & Outcomes Research Fellowship Program in the Jefferson College of Population Health, and Managing Director, Center for Research in Medical Education and Health Care, Sidney Kimmel Medical College, Thomas Jefferson University.

Dr. Maio’s research interests are in the areas of outcomes analysis and medication usage and policy. He has published more than 50 papers in peer-reviewed journals and presented his research at many national and international conferences. He is Principal Investigator on multi-year collaborative projects funded by various Healthcare Authorities in the Regione Emilia-Romagna, Italy, mainly looking at the appropriateness of medication prescribing for the elderly; the assessment of the quality of care in inpatient and outpatient settings; the impact of newly established Patient-Centered Medical Homes; and the development of models using administrative healthcare utilization data to profile individuals at risk of hospitalization for diseases amenable to case/disease management programs.

Dr. Maio is Associate Editor of the American Journal of Medical Quality, and serves as a reviewer for several professional journals, including JAMA-Internal MedicineThe LancetPharmacoepidemiology & Drug Safety, Age and Aging, and Drugs & Aging. He also serves as grant reviewer for the Italian Ministry of Health. Dr. Maio is a member of the Scientific Advisory Council for the European Union’s TO-REACH Project.  

Dr. Maio received his Doctor of Pharmacy degree from the University of Perugia (Italy), took the Italian Pharmacist Board Certification, and received both his MS in Pharmacology and his MS in Public Health from Thomas Jefferson University. He teaches Pharmacoepidemiology in the MS in Pharmacology program for the trainees in the National Institutes of Health (NIH) K30 Training Program. He lectures on health policy issues in the MS in Management of Healthcare Organizations, Faculty of Economics, University of Pisa, Italy. He also lectures on health services and outcomes research in the Residency Program of Hygiene and Preventive Medicine, School of Medicine, University of Parma, Italy. 

A few of Dr. Maio's other accomplishments are listed below:

  • Developed instruments to assess quality of care in both inpatient and outpatient settings using administrative healthcare databases
  • Conducted research on predictive modeling to identify segment of the population at risk of higher healthcare resource utilization
  • Designed and implemented a physician-focused, multimodal, quality improvement initiative that successfully reduced potentially inappropriate medication exposure in the older adult population
  • Conducted research on the impact of Patient-Centered Medical Home on utilization and outcomes of medical care
  • Investigated the impact of repurposed inexpensive and well-tolerated medications, such as metformin, statins and ACE inhibitors/ARBs, on survival in cancer patients
  • Conducted research on the effect of the Oncology Care Model on cancer care